Differential effects on CLL cell survival exerted by different microenvironmental elements

被引:58
作者
Ghia, P
Circosta, P
Scielzo, C
Vallario, A
Camporeale, A
Granziero, L
Caligaris-Cappio, F
机构
[1] Univ Vita Salute San Raffaele, Dept Oncol, I-20132 Milan, Italy
[2] Univ Turin, Dept Oncol Sci, Lab Canc Immunol, Inst Canc Res & Treatment, I-10060 Candiolo, TO, Italy
来源
CHRONIC LYMPHOCYTIC LEUKEMIA | 2005年 / 294卷
关键词
D O I
10.1007/3-540-29933-5_8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Selected micro environmental stimuli confer to leukemic cells a growth advantage and an extended survival. We aimed at dissecting the differential support provided by the different cellular components of the microenvironment where CLL cells accumulate. To this end we cultured purified CLL cells in vitro in the presence or absence of different accessory cells (stromal cells, autologous T lymphocytes) and/or soluble molecules (IL-4, sCD40L) and assessed the leukemic cell response in terms of cell viability and chemoattracting capacity. The results indicate that both T lymphocytes and stromal cells are involved in sustaining the survival of leukemic B cells, but indicate that their support is different in terms of time of onset and duration. T cells have a short-term support activity while stromal cells provide long-term support.
引用
收藏
页码:135 / 145
页数:11
相关论文
共 22 条
[1]   A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1) [J].
Bleul, CC ;
Fuhlbrigge, RC ;
Casasnovas, JM ;
Aiuti, A ;
Springer, TA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03) :1101-1109
[2]  
Burger JA, 2000, BLOOD, V96, P2655
[3]   Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells [J].
Burger, JA ;
Burger, M ;
Kipps, TJ .
BLOOD, 1999, 94 (11) :3658-3667
[4]  
Buske C, 1997, EXP HEMATOL, V25, P329
[5]   National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment [J].
Cheson, BD ;
Bennett, JM ;
Grever, M ;
Kay, N ;
Keating, MJ ;
OBrien, S ;
Rai, KR .
BLOOD, 1996, 87 (12) :4990-4997
[6]   Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia [J].
Chu, P ;
Deforce, D ;
Pedersen, IM ;
Kim, Y ;
Kitada, S ;
Reed, JC ;
Kipps, TJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (06) :3854-3859
[7]   The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression [J].
Ghia, P ;
Guida, G ;
Stella, S ;
Gottardi, D ;
Geuna, M ;
Strola, G ;
Scielzo, C ;
Caligaris-Cappio, F .
BLOOD, 2003, 101 (04) :1262-1269
[8]  
Ghia P, 2002, EUR J IMMUNOL, V32, P1403, DOI 10.1002/1521-4141(200205)32:5<1403::AID-IMMU1403>3.0.CO
[9]  
2-Y
[10]   The indispensable role of microenvironment in the natural history of low-grade B-cell neoplasms [J].
Ghia, P ;
Caligaris-Cappio, F .
ADVANCES IN CANCER RESEARCH, VOL 79, 2000, 79 :157-173